BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
April 6, 2005
View Archived Issues
PharmaMar's Yondelis Phase III Trial Started In Ovarian Cancer
Taking aim at relapsed ovarian cancer patients considered incurable, Madrid, Spain-based PharmaMar SA is starting a Phase III trial with Yondelis (trabectedin), a compound first isolated from marine tunicates. (BioWorld International)
Read More
Rosetta Genomics Brings In $4M For Preclinical Studies
Read More
Identifying Pre-Eclampsia Gene Could Bring Diagnostic Testing
Read More
Nautilus Biotech Gets EUR7.25M In Third Round Of Financing
Read More
Ark, Boehringer Ingelheim Form Collaboration Over IP
Read More
Syngenta Slip-Up Causes Red Faces Across European Union
Read More
Israeli Chief Scientist Designates Biotech, Nanotech High Priorities
Read More
Other News To Note
Read More